Sitra

Headai Ltd. is a Finnish company founded in 2015 that specializes in developing software robots designed to automate intellectual tasks across various business operations. The company offers teachable robots as a cloud service, enabling organizations to streamline repetitive processes and enhance efficiency. Headai's technology combines natural language processing, reinforcement learning, and insights from cognitive sciences to create interactive and reliable bots that can learn quickly and adapt to user needs. Additionally, Headai provides tools for discovering relevant content and accessing information tailored to individual interests, thereby supporting corporate learning and decision-making. By leveraging its proprietary algorithms, Headai helps clients uncover valuable insights from large datasets, facilitating a better understanding of complex information.

Optomeditech Oy, established in June 2011, specializes in the development and marketing of medical devices, specifically intravenous catheters and blood collection needles. The company focuses on enhancing patient and caregiver safety through innovative technology. Its products utilize transillumination of skin tissue to facilitate cannulation, thereby improving the success rate of first-time procedures for healthcare professionals. Currently, Optomeditech is in the process of obtaining CE mark and FDA 510(k) approvals for its inaugural IV catheter product, with plans to enter the market in the first half of 2015.

VisionPlus is a Finnish venture capital firm established in 2011, located in Helsinki. The firm focuses on investing in digital products, including applications, games, and services across various digital platforms. Its investment portfolio encompasses software-as-a-service, mobile applications, and internet services, as well as special content intellectual property deals. The management team at VisionPlus possesses extensive experience in technology, entrepreneurship, and seed investments, having successfully developed and managed large-scale business and development organizations in a global context.

Savo-Solar Oy, a Mikkeli, Finland-based manufacturer of solar thermal solutions.

Nexstim specializes in non-invasive brain stimulation technologies, focusing on navigated transcranial magnetic stimulation (TMS) for therapeutic and diagnostic applications. Its proprietary SmartFocus technology enables accurate targeting of specific brain areas. Nexstim's primary products are the NBT system for treating major depression or chronic pain, and the NBS system for pre-surgical brain mapping. Headquartered in Helsinki, Finland, Nexstim serves customers globally.

Nexstim specializes in non-invasive brain stimulation technologies, focusing on navigated transcranial magnetic stimulation (TMS) for therapeutic and diagnostic applications. Its proprietary SmartFocus technology enables accurate targeting of specific brain areas. Nexstim's primary products are the NBT system for treating major depression or chronic pain, and the NBS system for pre-surgical brain mapping. Headquartered in Helsinki, Finland, Nexstim serves customers globally.

Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces. BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi Arabia. The company was founded in 2001 and is based in Turku, Finland.

Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.

The company develops and delivers technology for converting ocean waves to electricity. AW-Energy has developed WaveRoller - a fully submerged wave energy converter which utilizes wave surge phenomenon. This commonplace effect is observed in near-shore waters where the circular motion of water particles present in open sea waves changes into elliptical circulation due to more shallow bottom. Before the waves break, typically at the depth of 8-20 metres this elliptical motion is so flat that it is essentially a horizontal back-and-forth movement of water. WaveRoller device is a Panel anchored at its base on the sea bed. The back and forth movement of the wave surge moves the Panel, transferring the kinetic energy to piston pumps. The pumps create a great deal of pressure which is fed into a combination of hydraulic motor/generator, which in turn produces electricity. The nominal capacity of a single commercial-scale Panel ranges between 500 – 1000 kW, depending on the wave resources available on the site. WaveRoller has the ability to generate energy on a wide spectrum of wave states and is also well suited for locations where wave periods are long and the swell is strong. A series of WaveRoller devices can be combined into an array, thus resulting in a wave farm. Since the plant construction is modular with a high degree of independence between individual units, there is no natural upper limit to the number of WaveRoller units that can be used, therefore offering a high level of scalability and reliability. The electricity output from an individual Panel is connected to a hub/substation, thus making it easy to plug-in new units in separate project development stages, as the new capacity is added to the farm. Also, any potential underperformance or service & maintenance breaks of individual units have no impact on the remaining units, thus ensuring uninterrupted power output from the overall farm. The first prototypes were designed and patent applications were filed as early as in 1999, when Rauno Koivusaari, the original inventor co-operated with Fortum Research Centre during the conceptual phase. Since then the technology has evolved following numerous laboratory and wave-tank test trials and ongoing mathematical simulations. Open sea trails started in 2004 and included the Gulf of Finland, marine tests conducted in the European Marine Energy Centre (EMEC), Scotland, and an own testing site in Peniche, Portugal. The subsequent successes and encouraging test results led to continuous increase in the scale of the demonstration plant. The latest demonstration plant/farm consisting of three 100kW WaveRoller units (total nominal capacity of the farm 300kW) is to be deployed in Peniche, Portugal, during the second quarter of 2012. The final assembly is nearing completion in the first quarter of 2012 and will be awaiting suitable weather conditions for the deployment in the following months. The farm will be connected to national grid in Portugal. The company has already secured all the necessary permits and, additionally, holds a licence for 1MW grid connection.